Literature DB >> 19447289

Force-plate quantification of progressive behavioral deficits in the R6/2 mouse model of Huntington's disease.

Stephen C Fowler1, Benjamin R Miller, Thomas W Gaither, Michael A Johnson, George V Rebec.   

Abstract

The R6/2 mouse is a popular model of Huntington's disease (HD) because of its rapid progression and measurable behavioral phenotype. Yet current behavioral phenotyping methods are usually univariate (e.g., latency to fall from a rotarod) and labor intensive. We used a force-plate actometer and specialized computer algorithms to partition the data into topographically specific behavioral categories that were sensitive to HD-like abnormalities. Seven R6/2 male mice and 7 wild-type (WT) controls were placed in a 42 cm x 42 cm force-plate actometer for 20-min recording sessions at 6-7, 8-9, 10-11 and 12-13 weeks of age. Distance traveled, number of wall rears, and number of straight runs (traveling 175 mm or more in 1.5s) were reduced in R6/2 relative to WT mice at all ages tested. Low mobility bouts (each defined as remaining continuously in a virtual circle of 15 mm radius for 5s) were increased in R6/2 mice at 6-7 weeks and beyond. Independent of body weight, force off-load during wall rears was reduced in R6/2 mice except at 6-7 weeks. Power spectra of force variation during straight runs indicated an age-related progressive loss of rhythmicity in R6/2 compared to WT, suggesting gait dysrhythmia and dysmetria. Collectively, these data, which extend results obtained with other widely different behavioral phenotyping methods, document a multifaceted syndrome of motor abnormalities in R6/2 mice. We suggest, moreover, that the force-plate actometer offers a high-throughput tool for screening drugs that may affect symptom expression in R6/2 or other HD model mice.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19447289      PMCID: PMC3711515          DOI: 10.1016/j.bbr.2009.03.022

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  31 in total

1.  Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation.

Authors:  R J Carter; L A Lione; T Humby; L Mangiarini; A Mahal; G P Bates; S B Dunnett; A J Morton
Journal:  J Neurosci       Date:  1999-04-15       Impact factor: 6.167

2.  Force plate for measuring the ground reaction forces in small animal locomotion.

Authors:  Ann C Zumwalt; Mark Hamrick; Daniel Schmitt
Journal:  J Biomech       Date:  2005-12-13       Impact factor: 2.712

3.  Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington's disease knock-in mice.

Authors:  Alejandro Lloret; Ella Dragileva; Allison Teed; Janice Espinola; Elisa Fossale; Tammy Gillis; Edith Lopez; Richard H Myers; Marcy E MacDonald; Vanessa C Wheeler
Journal:  Hum Mol Genet       Date:  2006-05-10       Impact factor: 6.150

Review 4.  Huntington's disease.

Authors:  Francis O Walker
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

5.  Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain.

Authors:  Jeremy M Van Raamsdonk; Martina Metzler; Elizabeth Slow; Jacqueline Pearson; Claudia Schwab; Jeffrey Carroll; Rona K Graham; Blair R Leavitt; Michael R Hayden
Journal:  Neurobiol Dis       Date:  2006-12-29       Impact factor: 5.996

6.  Early behavioral deficits in R6/2 mice suitable for use in preclinical drug testing.

Authors:  M A Hickey; K Gallant; G G Gross; M S Levine; Marie-Françoise Chesselet
Journal:  Neurobiol Dis       Date:  2005-10       Impact factor: 5.996

7.  Ground reaction forces in locomoting hemi-parkinsonian rats: a definitive test for impairments and compensations.

Authors:  G D Muir; I Q Whishaw
Journal:  Exp Brain Res       Date:  1999-06       Impact factor: 1.972

8.  Chronology of behavioral symptoms and neuropathological sequela in R6/2 Huntington's disease transgenic mice.

Authors:  Edward C Stack; James K Kubilus; Karen Smith; Kerry Cormier; Steven J Del Signore; Emmanuel Guelin; Hoon Ryu; Steven M Hersch; Robert J Ferrante
Journal:  J Comp Neurol       Date:  2005-10-03       Impact factor: 3.215

Review 9.  Knock-in mouse models of Huntington's disease.

Authors:  Liliana B Menalled
Journal:  NeuroRx       Date:  2005-07

10.  Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice.

Authors:  Jinhua Wu; Hong Zou; Judith A Strong; Jun Yu; Xuedong Zhou; Qinglian Xie; Guoping Zhao; Meilei Jin; Lei Yu
Journal:  Psychopharmacology (Berl)       Date:  2004-07-28       Impact factor: 4.530

View more
  19 in total

1.  Sensorimotor behavioral tests for use in a juvenile rat model of traumatic brain injury: assessment of sex differences.

Authors:  Kristin L Russell; Katrina M Kutchko; Stephen C Fowler; Nancy E J Berman; Beth Levant
Journal:  J Neurosci Methods       Date:  2011-05-11       Impact factor: 2.390

2.  Regulation of motor function and behavior by atypical chemokine receptor 1.

Authors:  Erich H Schneider; Stephen C Fowler; Michail S Lionakis; Muthulekha Swamydas; Gibran Holmes; Vivian Diaz; Jeeva Munasinghe; Stephen C Peiper; Ji-Liang Gao; Philip M Murphy
Journal:  Behav Genet       Date:  2014-07-06       Impact factor: 2.805

3.  Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.

Authors:  Ana María Estrada-Sánchez; Courtney L Blake; Scott J Barton; Andrew G Howe; George V Rebec
Journal:  J Neurophysiol       Date:  2019-11-06       Impact factor: 2.714

4.  Targeting Heat Shock Protein 70 to Ameliorate c-Jun Expression and Improve Demyelinating Neuropathy.

Authors:  Xinyue Zhang; Chengyuan Li; Stephen C Fowler; Zheng Zhang; Brian S J Blagg; Rick T Dobrowsky
Journal:  ACS Chem Neurosci       Date:  2017-11-09       Impact factor: 4.418

5.  Pramipexole enhances disadvantageous decision-making: Lack of relation to changes in phasic dopamine release.

Authors:  Romina Pes; Sean C Godar; Andrew T Fox; Lauren M Burgeno; Hunter J Strathman; David P Jarmolowicz; Paola Devoto; Beth Levant; Paul E Phillips; Stephen C Fowler; Marco Bortolato
Journal:  Neuropharmacology       Date:  2016-11-23       Impact factor: 5.250

6.  Motor function and dopamine release measurements in transgenic Huntington's disease model rats.

Authors:  Andrea N Ortiz; Gregory L Osterhaus; Kelli Lauderdale; Luke Mahoney; Stephen C Fowler; Stephan von Hörsten; Olaf Riess; Michael A Johnson
Journal:  Brain Res       Date:  2012-02-24       Impact factor: 3.252

7.  Use of a force-sensing automated open field apparatus in a longitudinal study of multiple behavioral deficits in CAG140 Huntington's disease model mice.

Authors:  Stephen C Fowler; Nancy A Muma
Journal:  Behav Brain Res       Date:  2015-07-22       Impact factor: 3.332

8.  Dysregulation of coordinated neuronal firing patterns in striatum of freely behaving transgenic rats that model Huntington's disease.

Authors:  Benjamin R Miller; Adam G Walker; Stephen C Fowler; Stephan von Hörsten; Olaf Riess; Michael A Johnson; George V Rebec
Journal:  Neurobiol Dis       Date:  2009-10-08       Impact factor: 5.996

9.  Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.

Authors:  George V Rebec
Journal:  Antioxid Redox Signal       Date:  2013-06-19       Impact factor: 8.401

10.  Assessing complex movement behaviors in rodent models of neurological disorders.

Authors:  Kenneth E McCarson; Michelle K Winter; Dale R Abrahamson; Nancy E Berman; Peter G Smith
Journal:  Neurobiol Learn Mem       Date:  2018-02-21       Impact factor: 2.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.